🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

PRESS DIGEST - Wall Street Journal - March 17

Published 2016-03-17, 01:25 a/m
© Reuters.  PRESS DIGEST - Wall Street Journal - March 17
NOVN
-
BHC
-
EMBR3
-
MDLZ
-
SQ
-

March 17 (Reuters) - The following are the top stories in
the Wall Street Journal. Reuters has not verified these stories
and does not vouch for their accuracy.

- William Ackman's Pershing Square (NYSE:SQ) Capital Management LP is
selling down his biggest investment as a disastrous bet on
Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO tears a hole
in its portfolio. The activist investor said his hedge fund sold
20 million shares in Mondelez International Inc MDLZ.O after
the market closed, which would yield $834 million at current
prices.

- Republicans on Wednesday didn't budge in their refusal to
consider Judge Merrick Garland, President Barack Obama's choice
for the Supreme Court, before this fall's elections. Following
this, the GOP's strategy could shift dramatically.

- It is just the start of the U.S. mosquito season, but
companies that make bug repellent are already running factories
near capacity as they anticipate surging demand in response to
the spread of the Zika virus.

- Peabody Energy Corp BTU.N warned Wednesday that it could
go bankrupt, signaling the end of an era for listed U.S.
corporate coal companies, even as their mines continue to fuel a
big chunk of the country's power stations.

- A sales consultant who said he paid bribes on behalf of
aircraft maker Embraer SA EMBR3.SA told Brazilian prosecutors
that he believes the company's top managers, including Chief
Executive Frederico Curado, knew of the illicit payments, which
were tied to the sale of military aircraft to the Dominican
Republic.

- Novartis AG NOVN.S has faced a problem in getting
doctors to prescribe its heart-failure pill, Entresto, since
winning regulatory approval for it in July. The drug had $21
million in sales in the six months following its launch, a
fraction of the $126 million expected by industry analysts.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.